,COVID-19

Anjali Patel1, Christine Cherian2, Derek Ge3

  • 1Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA; Cooper Medical School of Rowan University, Camden, NJ 08103, USA.

概括

患有多发性硬化症 (MS) 的患者面临严重的COVID-19结果和恶化的神经精神疾病症状的风险增加. 这凸显了在多发性硬化患者群体中需要仔细管理COVID-19的必要性.